InsidersTradesSigma
Biovica International AB Stock: price and management transactions · Finland · FIN-FSA
Follow the Biovica International AB stock price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares trade on FI FI, under the oversight of FIN-FSA. Operating in the Health Care sector, Biovica International AB has logged 6 public disclosures. Market capitalisation: €105.1m. The latest transaction was reported on 23 June 2026 (Purchase). Among the most active insiders: Fredrik Alpsten. All data is accessible without an account.
6
Insider Decl.
0
Thresholds
€111,753
5 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Biovica International AB Strong Buy (bullish), based on 1 analysts. Average price target: SEK 0.60.
37Σ signal
Fundamental score
Ranked 22,107 of 26,127 companies
26.9
score / 100
Value4
Quality50
FCF yld-57%
Earn yld-63%
EV/EBITDA·
ROE-108%
Gross mgn100%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 23 June 2026
Declarations6 total
199,170 shares@ SEK 0.3580.0060% mcap10.9% of flowAktieFI:csv-6cf8c17f64d4eacf24e4
Ideal exit: 19 Mar 2027 (T+270)
650,000 shares@ SEK 0.35530.019% mcap35.1% of flowAktieFI:csv-ab3fe402a8bf357c02f4
Ideal exit: 20 Mar 2027 (T+270)
1,000,000 shares@ €0.0320.032% mcap100.0% of flowAktieFI:A003U852-1
Ideal exit: 14 Sept 2026 (T+270)
606,762 shares@ €0.05670.034% mcap65.6% of flowAktieFI:A003S801-1
Ideal exit: 24 May 2026 (T+270)
180,000 shares@ €0.10020.018% mcap34.4% of flowAktieFI:A003M573-1
Ideal exit: 9 Dec 2025 (T+270)
127,000 shares0AktieFI:A001P457-1
6 of 6 declarations
About Biovica International AB
Biovica International AB is a company focused on developing diagnostic tests for cancer. It is listed on the XSTO market.